A significant shift in Canadian drug policy has happened, as the authorities permit the use of psilocybin hallucinogens for therapeutic purposes. Until now, these substances were severely restricted, but a growing body of research suggests they could offer relief for psychological illnesses like depression. This change represents a key step toward